Proteon Therapeutics, Inc. (PRTO)

[Jt0082]

Kiwi...in answer to your points:

1. I am an investor not a doc
2. Interesting point you raise about the length of fistula use. I think its interesting point you raise and I cant see any of this in the previously reported data but I am sure the company has been tracking?

My read is if it lasts past the 90 days (and surgeons didn't intervene to do balloon angioplasty) and it hasn't failed then it is generally a working fistula and wont be abandoned and will be used for life in general unless thrombosis? stenosis? So it is measured at say a year to see the difference between normal and vona and % increase. And that will dictate the success of vona.

I think surgeons are so attuned to intervening judging by all the balloon angioplasties and patency-1 failure so in this regard EVEN a minor improvement or difference and this drug would be used....